-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Heron Therapeutics, Inc. /De/ quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2010 to 2023.
- Heron Therapeutics, Inc. /De/ Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$9.52M, a 61.8% increase year-over-year.
- Heron Therapeutics, Inc. /De/ annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$58.8M, a 60% increase from 2022.
- Heron Therapeutics, Inc. /De/ annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$147M, a 27.8% increase from 2021.
- Heron Therapeutics, Inc. /De/ annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$203M, a 10% decline from 2020.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)